PACIRA PHARMACEUTICALS INC's ticker is PCRX and the CUSIP is 695127100. A total of 261 filers reported holding PACIRA PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.66 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $379,034 | -30.5% | 9,817 | -4.2% | 0.00% | -25.0% |
| Q3 2022 | $545,000 | -8.7% | 10,248 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $597,000 | -23.7% | 10,248 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $782,000 | +41.7% | 10,248 | +11.6% | 0.00% | +33.3% |
| Q4 2021 | $552,000 | -73.7% | 9,181 | -85.9% | 0.00% | -84.2% |
| Q4 2016 | $2,096,000 | +23.0% | 64,900 | +30.3% | 0.02% | +11.8% |
| Q3 2016 | $1,704,000 | +1.4% | 49,800 | 0.0% | 0.02% | -10.5% |
| Q2 2016 | $1,680,000 | +51.1% | 49,800 | +137.4% | 0.02% | +26.7% |
| Q1 2016 | $1,112,000 | -83.7% | 20,980 | -76.4% | 0.02% | -81.0% |
| Q4 2015 | $6,819,000 | -20.0% | 88,795 | -57.2% | 0.08% | -20.2% |
| Q3 2015 | $8,522,000 | -41.9% | 207,355 | 0.0% | 0.10% | -36.9% |
| Q2 2015 | $14,664,000 | +57.4% | 207,355 | +97.8% | 0.16% | +61.9% |
| Q1 2015 | $9,315,000 | – | 104,835 | – | 0.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Gagnon Advisors, LLC | 251,140 | $19,167,000 | 8.83% |
| GAGNON SECURITIES LLC | 610,933 | $46,626,000 | 7.60% |
| Tamarack Advisers, LP | 205,000 | $15,646,000 | 7.40% |
| Spyglass Capital Management LLC | 1,871,040 | $142,798,000 | 4.88% |
| Lisanti Capital Growth, LLC | 302,413 | $23,080,000 | 2.59% |
| Rock Springs Capital Management LP | 1,000,000 | $76,320,000 | 1.92% |
| MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income | 208,197 | $15,890,000 | 1.76% |
| JABODON PT CO | 49,052 | $3,744,000 | 1.70% |
| Zweig-DiMenna Associates LLC | 166,675 | $12,721,000 | 1.70% |
| NEUMEIER POMA INVESTMENT COUNSEL LLC | 317,425 | $24,226,000 | 1.63% |